top of page

NICE draft guidance recommends siponimod for treating secondary progressive multiple sclerosis

  • Oct 30, 2020
  • 1 min read


NICE has today (15 October 2020) issued draft guidance which now recommends siponimod (also called Mayzent and made by Novartis) for treating secondary progressive multiple sclerosis (MS).




1 Comment


Debbie Spence
Debbie Spence
Dec 30, 2020

I am a 64 year old female, I was diagnosed of Multiple Sclerosis (MS) in 2008, my symptoms started out with severe fatigue, poor balance, numbness, double vision, heat intolerance and anxiety. I was unable to go back to work, I tried Betaseron for about 6 years. Tried every shot available, all made me sick.In November 2015, I started on Multiple Sclerosis (MS) Herbal formula from Mayaka Natural Clinic, the treatment worked incredibly for my MS condition. I used the Mayaka MS Herbal formula for a total time period of 4 months, it totally reversed my Multiple Sclerosis. I had a total decline of all symptoms including vision problems, numbness and others. Sometimes, i totally forget i ever had MS.…

Like

Contact Us

Tel: +44 (0) 1603 626 960

Email: info@uropharma.com

©2017-2021 UroPharma, Inc. All Rights Reserved

3.png
2.png

Social Media

  • LinkedIn Social Icon

Linkedin.com/company/uropharma

  • Twitter

Twitter.com/UroPharma

  • Facebook

Facebook.com/bladdercontrol

4_edited_edited.jpg
image.png
bottom of page